Overview

• Apple has confirmed a partnership with Synchron to integrate brain-computer interface (BCI) technology into iPhones, iPads, and Vision Pro headsets.
• The Stentrode implant, developed by Synchron, is implanted through a vein near the brain's motor cortex, detecting neural signals to enable device control without physical input.
• This initiative builds on Apple’s Switch Control accessibility feature and a new BCI Human Interface Device (HID) protocol set to launch later in 2025.
• Early trials include an ALS patient successfully using the system to navigate Apple devices, though the technology remains slower than traditional inputs.
• Broader clinical trials and FDA approval are required before the technology can achieve widespread availability, which is expected to take several years.